VX1 vs syngo MBF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

VX1

by Volta Medical

syngo MBF

by Siemens Medical Solutions USA, Inc.

AI Verdict

These tools are adjacent within the broader field of Cardiology AI but serve distinct purposes. VX1 is designed for real-time assistance during cardiac ablation procedures, focusing on electrogram analysis to guide electrophysiologists. In contrast, syngo MBF is an imaging analysis tool for quantitative myocardial blood flow using PET scans, primarily aiding in cardiac diagnostics and therapy response assessment.

Choose VX1 if…

Choose VX1 if your primary need is real-time, AI-guided assistance during atrial fibrillation or atrial tachycardia ablation procedures. This tool is ideal for electrophysiologists seeking to enhance precision and standardize outcomes by identifying dispersed electrograms in real-time during live interventions.

View VX1 →

Choose syngo MBF if…

Choose syngo MBF if your focus is on comprehensive, AI-enhanced quantitative myocardial blood flow analysis using PET imaging for cardiac diagnostics. This software is best suited for clinicians requiring detailed assessment of myocardial perfusion and flow reserve, particularly for pre-procedural planning or post-therapy response evaluation.

View syngo MBF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	VX1	syngo MBF
Pricing	Contact for pricing	Contact vendor
Deployment	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.	On-premise (dedicated hardware), Virtualized environments (VMware, Hyper-V)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1

VX1 is described as intuitive, user-friendly, and simple to use, offering a simple user interface with real-time visual and sound cues during ablation procedures. Its design focuses on integrating seamlessly into existing electrophysiology lab workflows to augment expert decision-making. While syngo MBF also emphasizes streamlined workflows and automation within the syngo.via platform, VX1's direct, real-time guidance in an interventional setting provides a more immediate and tangible usability benefit.

Clinical Value

VX1

Both tools are FDA-cleared and offer significant clinical value in cardiology. VX1 has published clinical study results (Ev-AIFib) demonstrating its ability to standardize ablation outcomes and achieve high rates of freedom from atrial fibrillation, with an ongoing randomized controlled trial (TAILORED-AF) further validating its impact. Syngo MBF provides crucial quantitative diagnostic information for cardiac PET imaging, but VX1's direct impact on standardizing a complex interventional procedure and its strong initial clinical evidence give it a slight edge in demonstrated clinical value.

Pricing & Value

Tie

Both VX1 and syngo MBF require direct contact with the vendor for pricing information. Without transparent or publicly available pricing details for either product, it is impossible to conduct a meaningful head-to-head comparison of their pricing and overall value.

Enterprise Readiness

syngo MBF

Syngo MBF explicitly states that it is HIPAA compliant and that a Business Associate Agreement (BAA) is available, which are critical for handling Protected Health Information (PHI) in enterprise healthcare environments. It also offers flexible deployment options including on-premise and virtualized environments. In contrast, VX1 does not explicitly state HIPAA compliance or the availability of a BAA in the provided facts, which is a significant consideration for enterprise adoption.

Innovation

VX1

Both tools leverage AI for advanced medical applications. However, VX1 stands out as the first FDA-cleared AI tool for interventional cardiac electrophysiology, providing real-time AI guidance during complex ablation procedures to standardize outcomes and reduce variability. Its recognition with the prestigious Prix Galien Award for Best Startup further underscores its innovative impact in the field.

Support & Docs

syngo MBF

Siemens (Tool B) offers a robust and comprehensive support infrastructure, including a dedicated support center, an extensive document library with product manuals and knowledge bases, and various training resources. While Volta Medical (Tool A) provides a user manual and mentions training sessions, the breadth and formal structure of Siemens' publicly available support resources appear more extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	VX1	syngo MBF
Name	VX1	syngo MBF
Company	Volta Medical	Siemens Medical Solutions USA, Inc.
Primary Use Case	Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.	AI-enhanced software for quantitative myocardial blood flow (MBF) analysis using PET imaging for cardiac diagnostics and therapy response assessment.
Key AI Functionality	AI-guided real-time identification of dispersed electrograms (EGMs).	AI-enhanced quantitative Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) calculation, AI-powered Automatic Landmarking and Parsing of Human Anatomy (ALPHA).
Supported Procedure/Imaging Type	Atrial fibrillation and atrial tachycardia ablation procedures (analyzes 3D anatomical and electrical maps).	PET imaging (dynamic Rubidium-PET and Ammonia-PET images).
Integration/Compatibility	Compatible with most EP recording, 3D navigation systems, and mapping catheters.	Integrated within the syngo.via platform; Multi-modality image reading (via syngo.via platform).

Videos

Demos, reviews, and walkthroughs featuring VX1 and syngo MBF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what level of EHR integration can be expected for result reporting?

VX1 integrates directly into the EP lab workflow, assisting in real-time during ablation procedures by connecting with existing mapping and recording systems. syngo MBF, as part of the syngo.via platform, integrates into the imaging workflow for post-acquisition analysis of PET scans, with results available within that platform for review and potential DICOM and HL7 integration for reporting.

What specific metrics or features contribute to the accuracy and sensitivity of each tool in its respective clinical application?

VX1's accuracy is driven by its AI-guided real-time identification of dispersed electrograms, with a 'Booster mode' designed to increase sensitivity during atrial tachycardia or slow atrial fibrillation. syngo MBF enhances accuracy through quantitative Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) calculation, supported by features like motion compensation and residual activity correction for PET images.

Given their distinct applications, for which specific patient populations or clinical scenarios is each tool most clinically impactful?

VX1 is specifically designed for cardiac electrophysiologists performing AFib and atrial tachycardia ablation procedures, aiming to improve procedural outcomes by standardizing EGM identification and reducing inter-operator variability. syngo MBF is geared towards cardiologists, nuclear medicine physicians, and radiologists for quantitative myocardial blood flow analysis using PET imaging, aiding in cardiac diagnostics and therapy response assessment for conditions like coronary artery disease.

What is the expected learning curve for physicians and staff, and how quickly can a practice expect to see clinical or operational value from implementing each tool?

VX1 is designed to reduce inter-operator variability and standardize outcomes, suggesting a potentially faster learning curve for electrophysiologists by providing real-time, AI-enhanced guidance during complex procedures. syngo MBF, with its AI-powered Automatic Landmarking and Parsing of Human Anatomy (ALPHA) feature within syngo.via, is designed to accelerate workflow and standardize quantifications, which could lead to faster analysis and quicker diagnostic turnaround times for PET imaging.

Beyond standard compliance, what advanced security measures and audit-trail capabilities are built into these tools to protect patient data and ensure accountability?

While specific advanced security measures for VX1 are not detailed beyond general data protection, syngo MBF, as part of the Siemens syngo.via platform, incorporates built-in security controls such as user authentication, access restrictions, data encryption, and comprehensive auditing and logging of user actions via audit trails. These features are crucial for ensuring data integrity and accountability.

What are the key considerations for deploying these tools across multiple sites, and are customer references available to demonstrate successful multi-site implementations?

For VX1, multi-site rollout involves integration with each EP lab's existing mapping and recording systems, with studies like Ev-AIFib demonstrating reproducibility across multiple centers and operators. syngo MBF's deployment within the syngo.via platform suggests a more standardized rollout across sites already utilizing syngo.via, and Siemens Healthineers emphasizes its client-server architecture for integrated workflow across multiple modalities and locations.

What kind of technical and clinical support is provided by the vendor to ensure optimal performance and address any issues that may arise during use?

Volta Medical aims to drastically improve cardiac arrhythmia management and would typically provide technical and clinical support for their specialized EP software. Siemens Healthineers offers comprehensive support for syngo.via, including remote support, software updates, and dedicated managers for ongoing assistance and training, ensuring optimal performance and addressing issues throughout the product lifecycle.